Name: Impact of Mergers and Acquisitions on Indian Pharmaceutical Industry (en Inglés)
SKU: 57838757
Price: 1579.98 MXN
Availability: InStock
Author: Prabu, Keerthi
ISBN: 9786203303582

portada Impact of Mergers and Acquisitions on Indian Pharmaceutical Industry (en Inglés)

Impact of Mergers and Acquisitions on Indian Pharmaceutical Industry (en Inglés)

Formato

Libro Físico

Autor

Keerthi Prabu

Editorial

LAP Lambert Academic Publishing

Idioma

Inglés

N° páginas

192

Encuadernación

Tapa Blanda

Dimensiones

22.9x15.2x1.1 cm

Peso

0.29 kg.

ISBN13

9786203303582

Categorías

Empresa y gestión

Impact of Mergers and Acquisitions on Indian Pharmaceutical Industry (en Inglés)

Keerthi Prabu (Autor) · LAP Lambert Academic Publishing · Tapa Blanda

Libro Nuevo Importado

Envío: 22 a 27 días háb.

$ 2,633.30$ 1,579.98

-40%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 10 unidades

$ 1,579.98

¡Envío Gratis! Llega entre el 07 Oct y el 15 Oct a CUAUHTÉMOC, Ciudad de México. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Impact of Mergers and Acquisitions on Indian Pharmaceutical Industry (en Inglés)"

The study seeks to analyze the impact of mergers and acquisitions (M&A) on stochastic production frontier in Indian pharmaceutical industry during pre and post-merger period. Globalization compelled firms to restructure their operations in various ways and M&A played a significant role for firms in reconfiguration of their production and managerial operations and provided firms an opportunity to avail economies of scale and scope by integrating assets, marketing and production strategies. These major factors resulting in this sudden growth of merger and acquisition deals in India are favorable government policies, capital flow, economic stability, corporate investments, and changing attitude of Indian companies. The Indian pharmaceutical industry has been chosen for the proposed study period, the study a total time span of 24 years covers during pre (1994-95 to 2003-04) and post (2004-05 to 2016-17) merger periods. The study was completely based on secondary data compiled from Ministry of Statistics and Programme Implementation (MOSPI) and PROWESS database. The results suggest that the average production function is an inadequate representation of the Indian pharmaceutical industry